Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD... von Thomson, Professor David, Slevin, Professor Nick, Baines, Helen, Betts, Guy, Bolton, Steve, Evans, Professor Mererid, Garcez, Kate, Irlam, Joely, Lee, Lip, Melillo, Nicola, Mistry, Hitesh, More, Elisabet, Nutting, Professor Christopher, Price, James, Schipani, Stefano, Sen, Mehmet, Yang, Huiqi, West, NIMRAD Trial Group, Professor Catharine

Volltext